Elizabeth A. Lopes is a medicinal chemist with expertise in organic synthesis, analytical methods, molecular modeling, and flow analysis. She holds a doctorate in Pharmacy from the University of Lisbon, where her research focused on developing novel scaffolds and reactivators of p53 targeting cancer and malaria. Her work contributed to the discovery of potent bioactive compounds and advanced strategies for hit-to-lead optimization. With extensive experience across leading European laboratories, Elizabeth has excelled in designing innovative synthetic routes, synthesizing and characterizing bioactive small molecules, and establishing structure-activity relationships to enhance drug efficacy. Her computational chemistry expertise includes molecular docking, molecular dynamics, target fishing, and ADME prediction using tools such as Schrodinger Suite, MOE, and PyMOL. She is also skilled in flow analysis techniques, having performed drug quantification and pharmacokinetic studies using sequential injection lab-on-valve systems. Elizabeth’s contributions extend beyond research; she has published over 10 peer-reviewed articles in high-impact journals, presented her findings at more than 25 conferences, and received grants and awards. She has collaborated on interdisciplinary projects, and worked across diverse fields, from antimalarial drug discovery to cancer therapies.